Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5696-5700
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696
Table 3 Relation between expressions of biological markers and response of esophageal squamous cell carcinoma to CRT (n)
| Markers | Responder | Non-responder | P |
| (CR+PR) | (NC+PD) | ||
| Bax (-) | 17 | 8 | 0.799 |
| Bax (+) | 8 | 3 | 0.799 |
| Bcl-2 (-) | 18 | 8 | 0.836 |
| Bcl-2 (+) | 7 | 3 | 0.836 |
| Cyclin D1 (-) | 15 | 6 | 0.305 |
| Cyclin D1 (+) | 10 | 5 | 0.305 |
| VEGF (-) | 10 | 5 | 0.936 |
| VEGF (+) | 15 | 6 | 0.936 |
| Ki67 (-) | 4 | 1 | 0.586 |
| Ki67 (+) | 21 | 10 | 0.586 |
- Citation: Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5696.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5696